Sotera Health Company (SHC) – What Are Investment Firms Saying About This Stock?

Sotera Health Company (NASDAQ:SHC) has earned an average rating of “Moderate Buy” from the ten research firms that are presently covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and seven have assigned a buy recommendation to the company. The average twelve-month price objective among analysts that have updated their coverage on the stock in the last year is $21.14.

A number of equities analysts recently commented on SHC shares. JPMorgan Chase & Co. lowered their target price on shares of Sotera Health from $17.00 to $15.00 and set an “underweight” rating for the company in a research note on Wednesday, November 4th. Citigroup lifted their price target on Sotera Health from $23.00 to $25.00 and gave the stock a “buy” rating in a report on Friday, August 7th. Piper Sandler reiterated an “overweight” rating and issued a $25.00 price objective on shares of Sotera Health in a report on Tuesday, September 8th. Weiss Ratings lowered shares of Sotera Health from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Friday, October 23rd. Finally, Wall Street Zen cut shares of Sotera Health from a “strong-buy” rating to a “buy” rating in a report on Saturday, November 7th.

Insiders Place Their Bets

In other Sotera Health news, Chairman Michael B. Jr. Petras sold 850,000 shares of the firm’s stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $18.50, for a total transaction of $15,725,000.00. Following the transaction, the chairman owned 3,969,393 shares of the company’s stock, valued at approximately $73,433,770.50. This trade represents a 17.64% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 15.36% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Sotera Health

A number of institutional investors have recently modified their holdings of the business. Mirae Asset Global Investments Co. Ltd. purchased a new stake in Sotera Health in the 3rd quarter valued at $29,000. Meeder Asset Management Inc. purchased a new position in Sotera Health during the 2nd quarter worth $37,000. Provenance Wealth Advisors LLC acquired a new position in Sotera Health in the third quarter valued at $42,000. Nykredit A S acquired a new position in Sotera Health in the second quarter valued at $50,000. Finally, IFP Advisors Inc raised its holdings in shares of Sotera Health by 150.8% in the second quarter. IFP Advisors Inc now owns 3,509 shares of the company’s stock valued at $62,000 after buying an additional 2,110 shares during the last quarter. 91.03% of the stock is owned by institutional investors and hedge funds.

Sotera Health Stock Up 1.9%

Shares of SHC traded up $0.31 during midday trading on Friday, hitting $16.61. The company had a trading volume of 2,647,530 shares, compared to its average volume of 2,660,564. The company’s 50-day simple moving average is $17.96 and its 200-day simple moving average is $16.91. The company has a debt-to-equity ratio of 3.04, a quick ratio of 2.91 and a current ratio of 3.13. The firm has a market capitalization of $4.74 billion, a P/E ratio of 27.68 and a beta of 1.94. Sotera Health has a 1 year low of $13.09 and a 1 year high of $19.85.

Sotera Health (NASDAQ:SHC) last announced its quarterly earnings data on Tuesday, November 3rd. The company reported $0.29 EPS for the quarter, topping analysts’ consensus estimates of $0.27 by $0.02. Sotera Health had a return on equity of 38.46% and a net margin of 14.11%. The business had revenue of $324.89 million during the quarter, compared to the consensus estimate of $319.86 million. During the same period in the previous year, the company posted $0.26 earnings per share. The business’s revenue for the quarter was up 4.4% on a year-over-year basis. As a group, sell-side analysts expect that Sotera Health will post 0.89 EPS for the current year.

About Sotera Health

Sotera Health Company is a global provider of sterilization, laboratory testing and advisory services for the medical device, pharmaceutical and food industries. Its services help customers assess product safety, meet regulatory requirements and prepare products for use. Through Sterigenics, the company provides contract sterilization using technologies including ethylene oxide, gamma irradiation and electron beam processing. Nelson Labs offers microbiological and analytical testing, as well as consulting, for medical devices and pharmaceutical products.